INDEPENDENT VERDICT
Redemption MRE Income Fund LLC is best understood as a strategic pivot inside an existing Redeem Investments platform rather than as a first-time real estate sponsor. Its original September 2025 Form D reported a $50 million Rule 506(c) commercial real estate offering with $0 sold. The September 11, 2026 amendment now reports $3,624,652 sold to five investors, a $100,000 minimum and a September 30, 2025 first sale. More important than the fundraising increase is how specifically the sponsor now defines the assets: Redeem Investments markets the MRE Income Fund around medical real estate leased to healthcare operators under long-term absolute NNN structures, including specialty dental clinics and ambulatory surgical centers. That strategy is materially different from Redeem's earlier ARMOR Fund, which focused on adaptive reuse of underutilized office and hospitality properties into medical, hotel and other higher-value uses. The 2026 MRE vehicle therefore represents a move toward stabilized healthcare tenancy and contractual income rather than relying primarily on redevelopment upside.
THE FUND'S MOST IMPORTANT SEC DISCLOSURE IS NOT THE $50 MILLION TARGET — IT IS THE $726,088 RELATED-PERSON PAYMENT
The September amendment estimates that $726,088 of gross offering proceeds will be used for payments to persons required to be named in the filing, with the clarification "Acquisition Fees and Project Management Fees." Against $3,624,652 currently reported sold, that estimated amount is economically significant and deserves direct explanation from the sponsor. The Form D does not say whether the $726,088 has already been paid, whether it scales with future acquisitions, which named person or affiliated entity receives each fee, or whether those fees are transaction-specific. It also reports $0 sales commissions and $0 finder's fees, so the main visible sponsor-side economics in the filing sit inside acquisition and project-management compensation rather than securities-distribution expenses. Investors therefore need to distinguish property-level acquisition fees, construction/project-management fees, ongoing asset-management fees and any promote or carried economics instead of assuming the absence of brokerage commissions means the structure has low fees.
REDEEM'S PUBLIC MATERIALS GIVE THE MRE STRATEGY FAR MORE ASSET DETAIL THAN THE FORM D
Redeem Investments describes itself as a medical real estate investor focused primarily on net-leased properties in the U.S. Sunbelt, targeting ambulatory surgical centers, medical, dental and veterinary clinics, urgent-care facilities, infusion and dialysis centers, rehabilitation hospitals and senior-care assets. The MRE Income Fund offering portal says its initial acquisitions include specialty dental clinics and an ambulatory surgical center leased for 10–30 years on absolute NNN terms, meaning tenants are expected to bear taxes, insurance, maintenance and capital expenses. Sponsor marketing also claims approximately $7 million of "built-in equity" across the first two assets and projects approximately 8% cash-on-cash distributions, 13–16% IRR and a 1.8x equity multiple. Those are sponsor projections, not SEC-verified performance or guaranteed returns, and FilingDossier would not repeat them as realized economics. What they do provide is a concrete way to test the fund: investors can ask for purchase prices, independent appraisals, tenant guarantees, lease terms and property-level debt to determine whether the claimed day-one equity and income profile are supported by transaction documents.
THE TEAM HISTORY SHOWS A REAL OPERATING PLATFORM — BUT ALSO A STRATEGY EVOLUTION THAT SHOULD BE UNDERSTOOD
Christian Catron is identified by Redeem as Founder, President and CEO, with a healthcare-industry operating background before moving into commercial real estate. The 2026 Form D names Catron, Eric Acheson and Arthur Johnson as directors; earlier Redeem SEC filings also included Michael Euperio. Redeem's older public record was centered on multifamily value-add projects and later the Redemption ARMOR Fund, which Catron described as "Adaptive Reuse & Medical Office Realty." ARMOR pursued projects such as an office-to-Courtyard Marriott conversion in Temple, a medical-office/coworking project in San Antonio and ambulatory surgery-center transactions. The current MRE fund narrows that broader adaptive-reuse thesis into medical properties intended to produce contract-based rent. That shift may reduce construction and lease-up dependence if assets are acquired occupied under long-term leases, but it increases tenant-credit concentration, lease-guarantee and specialized-building re-leasing risk. Redeem's prior full-cycle multifamily record is relevant sponsor history, but it is not direct evidence of how this new medical NNN portfolio will perform.
FINAL ASSESSMENT
Redemption MRE Income Fund is distinguishable by at least five specific facts: it moved from $0 sold in 2025 to $3.624 million across five investors by September 2026; the sponsor has deliberately shifted from its earlier adaptive-reuse ARMOR strategy toward medical NNN assets; the offering explicitly discloses an estimated $726,088 of acquisition and project-management fees; the sponsor identifies specialty dental and ambulatory surgical center assets as initial acquisitions; and Redeem publicly claims long 10–30 year absolute NNN lease structures plus approximately $7 million of acquisition-basis equity across the first two properties. The most important diligence questions are therefore tenant credit, property-level leverage, independent support for the "built-in equity" claim and the complete fee waterfall. The $50 million figure is only the maximum raise; current SEC sales are still below $4 million, and projected 8% cash yield or 13–16% IRR figures remain sponsor forecasts rather than realized fund results.
SEC SNAPSHOT
Issuer: Redemption MRE Income Fund LLC CIK: 0002084967 SEC Form: Form D/A Accession No.: 0002084967-26-000003 Latest Filing Date: September 11, 2026 Original Filing Date: September 24, 2025 Year Organized: 2025 Jurisdiction: Texas Principal Address: 1779 Wells Branch Pkwy, Ste. 110B-371, Austin, TX 78728 Telephone: 512-269-0041 Industry: Commercial Real Estate Offering Exemption: Rule 506(c) Security Types: Equity / Pooled Investment Fund Interests Investment Company Act Exclusion: None claimed in reviewed amendment Offering Amount: $50,000,000 Amount Sold - September 2025: $0 Amount Sold - September 2026: $3,624,652 Remaining: $46,375,348 Investors: 5 Minimum Investment: $100,000 First Sale: September 30, 2025 Offering Duration Over One Year: Yes Sales Commissions: $0 Finder's Fees: $0 Estimated Related-Person Payments: $726,088 Use of Proceeds Clarification: Acquisition Fees and Project Management Fees Named Director: Christian Catron Named Director: Eric Acheson Named Director: Arthur Johnson Signer: Byron Elliott Signer Role: Attorney
REDEEM PLATFORM / STRATEGY PENETRATION
Official Operating Brand: Redeem Investments Official Website: redeeminvestments.com Founder / CEO: Christian Catron Medical Real Estate Focus Confirmed by Official Website: YES Sunbelt Focus Publicly Stated: YES Ambulatory Surgical Centers Targeted: YES Dental / Medical Clinics Targeted: YES Urgent Care / Emergency Centers Targeted: YES Infusion / Dialysis Centers Targeted: YES Rehabilitation / Skilled Nursing / Senior-Care Assets Targeted: YES Absolute NNN Lease Strategy Publicly Described: YES 10-30 Year Lease Terms Claimed by Sponsor: YES Tenant Responsibility for Taxes / Insurance / Maintenance Publicly Described: YES
MRE FUND ECONOMIC CLAIMS
Sponsor-Projected Cash-on-Cash Return: Approximately 8% Sponsor-Projected IRR: 13%-16% Sponsor-Projected Equity Multiple: 1.8x Sponsor-Claimed Built-In Equity Across First Two Assets: Approximately $7 million Initial Specialty Dental Assets Publicly Described: YES Initial Ambulatory Surgical Center Asset Publicly Described: YES Those Projected Returns SEC-Verified: NO Those Returns Realized as of September 2026: NOT ESTABLISHED Independent Appraisals Supporting $7M Built-In Equity Publicly Reviewed: NO
HISTORICAL STRATEGY EVOLUTION
Earlier Redeem Multifamily Activity: Confirmed Redeem 44-Unit Arlington Full-Cycle Sale Publicly Discussed: YES Sponsor-Reported Equity Multiple on That Historical Deal: 1.7x Historical Deal Comparable Directly to MRE Fund: NO
Redemption ARMOR Fund Publicly Confirmed: YES ARMOR Meaning: Adaptive Reuse & Medical Office Realty Office-to-Hotel Conversion Strategy: Confirmed publicly Medical Office Adaptive Reuse: Confirmed publicly Ambulatory Surgery Center Transactions: Confirmed publicly ARMOR Fund Identical to Redemption MRE Income Fund: NO MRE Fund Represents More Income-Oriented Medical Real Estate Strategy: Supported by sponsor materials
WEBSITE / ENTITY PENETRATION
Redemption MRE Income Fund SEC issuer confirmed: YES Redeem Investments official website confirmed: YES SEC issuer address matches Redeem operating address: YES SEC issuer telephone matches public Redeem address records: YES Christian Catron SEC relationship confirmed: YES Christian Catron Founder / CEO role confirmed by official website: YES Eric Acheson SEC relationship confirmed: YES Michael Euperio historical Redeem operating relationship confirmed: YES Arthur Johnson SEC relationship confirmed: YES Dedicated MRE investor portal confirmed: YES MRE PPM referenced in investor portal: YES MRE Operating Agreement referenced: YES MRE Subscription Agreement referenced: YES Independent SEC-registered adviser identified: NO Adviser CRD / SEC 801 confirmed: NO Broker-dealer identified in Form D: NO Fund-level auditor publicly confirmed: NO Fund administrator publicly confirmed: NO Custodian publicly confirmed: NO
CORE INVESTOR QUESTIONS
Which exact medical properties are currently owned by Redemption MRE Income Fund What were the purchase prices of the first specialty dental and ambulatory surgery-center assets What independent appraisals support the claimed approximately $7 million of built-in equity How much property-level debt is attached to each acquisition What are the interest rates, maturities and loan-to-value ratios Who are the healthcare tenants Which tenant obligations are guaranteed by operating companies or parent entities What percentage of fund rent comes from the largest tenant Are the leases truly absolute NNN for capital expenditures as well as operating expenses What happens if a specialized medical tenant defaults How easily can a surgery center or dental property be re-leased to a replacement operator How was the $726,088 acquisition / project-management fee estimate calculated Which individuals or affiliates receive those fees Are additional asset-management fees charged annually Is there carried interest or a sponsor promote Are acquisition fees calculated on purchase price, equity or total capitalization How much of the 13%-16% projected IRR depends on exit appreciation versus current cash flow How much of the projected 8% cash-on-cash return is currently covered by actual property NOI What tax deductions are based on cost segregation or accelerated depreciation Who provides independent accounting, audit, administration and custody
PRIMARY EVIDENCE REVIEWED
SEC Form D/A for Redemption MRE Income Fund LLC filed September 11, 2026. Original SEC Form D for Redemption MRE Income Fund LLC filed September 24, 2025. SEC filing confirming $50 million offering, $3,624,652 sold, five investors, $100,000 minimum and Rule 506(c). SEC filing disclosing estimated $726,088 of acquisition and project-management fees. Redeem Investments official website. Redeem Investments official founder biography for Christian Catron. Redeem Investments official educational materials concerning the earlier Redemption ARMOR Fund. Redemption MRE Income Fund investor portal and offering overview. Sponsor webinar describing initial medical assets, absolute NNN lease structure, projected returns and claimed built-in equity. Historical Redeem investment records and public discussion of prior multifamily projects used only as sponsor-history evidence.
IMPORTANT FORM D NOTICE
Redemption MRE Income Fund's $50 million figure is its stated maximum offering amount, not current assets under management. The September 2026 amendment reports $3,624,652 sold to five investors. The approximately 8% cash-on-cash return, 13%-16% IRR, 1.8x equity multiple and approximately $7 million of built-in equity are sponsor-presented projections or claims and are not SEC-verified results. The SEC filing does, however, independently disclose an estimated $726,088 of acquisition and project-management fees, which should be reconciled against the PPM and property-level transaction documents before evaluating projected net returns.